LSI USA '23 filling fast. Register Now

Cognoptix (fka Neuroptix)

The first early-stage, noninvasive combination drug-device diagnostic test for Alzheimer\'s disease; detects beta amyloid aggregates in the lens of th...

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Cognoptix (fka Neuroptix) plus 5337 other startups.

Start Free 7 Day Trial Now

Learn More About Cognoptix (fka Neuroptix)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More

Our Clients